Yu-Chiao Chiu, PhD

Acute myeloid leukemia (AML) is a type of cancer that is very difficult to cure because of relapse, so we need better ways to treat it. Pharmacogenomics is a way to study how genes and drugs interact, which could help us find better treatments for AML. Researchers of this study have developed artificial intelligence methods that can use information about genes and drugs to predict how well a patient will respond to treatment. However, these methods need to be improved to work specifically for AML. The researchers plan to develop new computer programs that are better at predicting how well AML patients will respond to treatment. They hope this will help doctors choose the best treatment for each patient, and improve their chances of getting better.